Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Check Cap Ltd

MBAI ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$8.72

▼ -1.25%

Market Cap $11.79M · Vol 3.47K

Key Metrics

P/E Ratio

1.88

FWD: N/A

Market Cap

$11.79M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

61.65

Momentum

Beta

0.87

vs Market

52W High

$27.37

68.14% below

52W Low

$4.34

100.73% above

Volume

3.47K

Avg 1.61K

P/B

3.31

Price-to-book

ROE

N/A

Return on equity

Free Float

72.20%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Check Cap Ltd (MBAI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MBAI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-11.65%

+10.24%

-30.41%

-32.30%

YTD

-23.10%

+87.30%

-60.07%

-94.23%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$4.14M
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	105.30% · N/A

P/E Ratio	1.88
Forward P/E (FY1)	N/A
PEG Ratio	0.02
P/S	N/A
P/B	3.31
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	1.35M

Technical Indicators

50-Day SMA	$8.53
200-Day SMA	$10.96
RSI (14)	61.65
Beta	0.87
52-Week High	$27.37
52-Week Low	$4.34

Volume Today	3.47K
Avg Daily Volume (30D)	1.61K
Relative Volume	2.16x
Volatility (10D)	102.99
Volatility (30D)	90.78
Free Float	72.20%

Analyst Consensus

N/A

Current Price $8.72

Mean Target N/A

52W Low$4.34 52W High$27.37

Current

Target

$4.34 $27.37

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG0089RJWL9

ISINIL0011336851

CountryIsrael

Sub-IndustryBio Diagnostics & Testing

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ADPT Adaptive Biotechnologies Corp +1.14% VCYT Veracyte Inc -3.17% IOVA Iovance Biotherapeutics Inc +7.06% 300676.SZ BGI Genomics Co Ltd -3.10% CDNA CareDx Inc -4.35%

Company Profile

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. Its capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps and other structural abnormalities. C-Scan is a non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.